Mastering Migraine Therapies

Mastering Migraine Therapies is a comprehensive program designed to provide a multi-faceted approach to migraine education. The program covers the diagnosis and treatment of migraine, and updates on the latest science.

Education on Demand

New for 2024, Mastering Migraine Therapies is available virtually via the AHS Education On Demand platform at no cost to AHS members. The program will center around pre-recorded lectures on new acute migraine treatment, prevention, and diagnosis, behavioral enhancements in migraine management, integrating neuromodulation into clinical practice, and migraine in children and adolescents.

Access Mastering Migraine Therapies and other educational resources via the AHS Education On Demand virtual platform. Not a member? Learn More here.

Live Q&A for CME

Registrants will also have access to register separately for live Q&A sessions with migraine experts for additional CME via the Education On Demand platform. Registrants are encouraged to view the On Demand content first, then register for an available Live Q&A that works for your schedule. Experts will cover various topics including the following frequently asked questions:

  • How do you select which patients are candidates for new therapies?
  • Can you safely combine CGRP therapies  with other drugs?
  • Can you combine a CGRP monoclonal antibody with Onabotulinum toxin A or with a CGRP receptor antagonist (gepant)?
  • Can you combine a gepant with a triptan or a ditan?
  • When do you recommend neuromodulation?
  • What behavioral treatments work the best for people with migraine?
  • Which of the newer treatment options would you consider to treat migraine during pregnancy or lactation?
  • What are some treatment options for people with migraine who are above 60?
  • Have these newer treatments been studied in children?
  • Do the newer treatments work for menstrual migraine?

Program Chairs

Michael J. Marmura, MD, FAHS
Thomas Jefferson University, Jefferson Headache Center

Philadelphia, Pennsylvania

Claire Sandoe, MD, MS
University of Toronto, Women’s College Hospital

Toronto, Ontario

Committee Members

Richard B. Lipton, MD, FAHS
Past Chair Advisor, Albert Einstein College of Medicine

Bronx, NY

Stephen D. Silberstein, MD, FAHS
Past Chair Advisor, Thomas Jefferson University, Jefferson Headache

Philadelphia, PA

Dawn C. Buse, PhD, FAHS

San Diego, CA

Deborah I. Friedman, MD, MPH, FAHS

Toronto, Ontario

Peter J. Goadsby, MD, PhD, FAHS
University of California, Los Angeles, UCLA Goldberg Migraine Program

Los Angeles, CA

Rashmi B. Halker Singh, MD, FAHS
Mayo Clinic

Scottsdale, AZ

Scott W. Powers, PhD, ABPP, FAHS
Cincinnati Children’s Hospital Medical Center

Cincinnati, OH

Todd J. Schwedt, MD, MSCI, FAHS
Mayo Clinic

Phoenix, AZ

Stewart J. Tepper, MD, FAHS
The New England Institute for Neurology and Headache

Stamford, CT

Kaitlin Greene, MD
Oregon Health and Science University

Portland, OR

Rashmi Rao, MD
Louisiana State University Health Sciences Center Children’s Hospital

New Orleans, LA